Robert L. Davis
Impact in
- Health top 0.1%
- Vaccine Coverage and Hesitancy
- Molecular Biology top 0.2%
- Muscle Physiology and Disorders
- RNA Research and Splicing
- Ubiquitin and proteasome pathways
- Pluripotent Stem Cells Research
- Genomics and Chromatin Dynamics
Papers in
- Health 41
- Vaccine Coverage and Hesitancy 37
- Co-authors
- Harold WeintraubAndrew B. LassarDavid L. TurnerDaniel LockshonRobert BenezraStephen J. TapscottMathew J. ThayerFrank DeStefano
- Journals
- PEDIATRICS (27 papers)Pharmacoepidemiology and Drug Safety (18 papers)Vaccine (8 papers)Science (7 papers)The Pediatric Infectious Disease Journal (7 papers)
- Partner nations
- United StatesCanadaThailand
In The Last Decade
Robert L. Davis
294 papers receiving 25.2k citations
Hit Papers
Peers
Comparison fields: 5 of 198
- Health 2.0k
- Molecular Biology 11.7k
- Applied Microbiology and Biotechnology 321
- Toxicology 532
- Aging 253
Countries citing papers authored by Robert L. Davis
This map shows the geographic impact of Robert L. Davis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert L. Davis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert L. Davis more than expected).
Fields of papers citing papers by Robert L. Davis
This network shows the impact of papers produced by Robert L. Davis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert L. Davis. The network helps show where Robert L. Davis may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Robert L. Davis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2026 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 1 | |
| 5 | 2025 | 2 | |
| 6 | 2024 | 9 | |
| 7 | 2024 | 0 | |
| 8 | 2024 | 5 | |
| 9 | 2024 | 2 | |
| 10 | 2022 | 3 | |
| 11 | 2021 | 21 | |
| 12 | 2015 | 339 | |
| 13 | 2013 | 23 | |
| 14 | 2013 | 11 | |
| 15 | 2012 | 143 | |
| 16 | 2011 | 149 | |
| 17 | 2009 | 3 | |
| 18 | Monitoring of drugs with a narrow therapeutic range in ambulatory care. | 2006 | 26 |
| 19 | 2002 | 75 | |
| 20 | 2000 | 44 |
About Robert L. Davis
Robert L. Davis is a scholar working on Health, Family Practice, Geriatrics and Gerontology, Applied Microbiology and Biotechnology and Toxicology, having authored 303 papers that have together received 26.2k indexed citations. Recurring topics across this work include Vaccine Coverage and Hesitancy (37 papers), Influenza Virus Research Studies (28 papers), Pneumonia and Respiratory Infections (18 papers), Respiratory viral infections research (17 papers), Pharmaceutical studies and practices (15 papers), Muscle Physiology and Disorders (14 papers), Pregnancy and Medication Impact (13 papers) and Pharmaceutical Practices and Patient Outcomes (13 papers). The work is most often cited by research in Health (2.0k citations), Molecular Biology (11.7k citations), Applied Microbiology and Biotechnology (321 citations), Toxicology (532 citations) and Aging (253 citations). Robert L. Davis has collaborated with scholars based in United States, Canada and Thailand. Frequent co-authors include Harold Weintraub, Andrew B. Lassar, David L. Turner, Daniel Lockshon, Robert Benezra, Stephen J. Tapscott, Mathew J. Thayer, Frank DeStefano, Richard Platt and Steven Black. Their work appears in journals such as PEDIATRICS, Pharmacoepidemiology and Drug Safety, Vaccine, Science and The Pediatric Infectious Disease Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.